Skeletal Muscle Metastasis in Papillary Thyroid Microcarcinoma Evaluated by F18-FDG PET/CT.

18F-fludeoxyglucose positron emission tomography computed tomography FDG PET/CT TENIS syndrome muscle metastasis papillary microcarcinoma papillary thyroid carcinoma solitary muscle metastasis thyroglobulin

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
12 Feb 2020
Historique:
received: 18 01 2020
revised: 10 02 2020
accepted: 11 02 2020
entrez: 16 2 2020
pubmed: 16 2 2020
medline: 16 2 2020
Statut: epublish

Résumé

Papillary thyroid cancer (PTC) is the most common type of thyroid malignancy and is characterized by slow growth and an indolent biological behavior. Papillary thyroid microcarcinoma is the PTC with the maximum size of the tumor <1cm, considered the most indolent form of thyroid cancer. PTC is usually metastasizes in cervical lymph nodes, lungs and bones and, less commonly, in brain or liver. Skeletal muscle metastases from PTC are extremely rare, a retrospective review of the literature revealed only 13 case reports. Among them, six cases are solitary skeletal muscle metastases, and seven are multiple metastases, most of them being associated with lung lesions. It seems that PTC is prone to metastasizing to the erector spinae and thigh muscles groups with unique cases located in trapezoid, biceps, deltoid, gastrocnemius and rectus abdominis muscles. Although extremely rare, one must bear in mind the fact that muscle metastasis from PTC is possible, and that is the reason we would like to discuss the existing clinical cases and to add a unique case of solitary skeletal muscle metastasis from papillary microcarcinoma.

Identifiants

pubmed: 32059570
pii: diagnostics10020100
doi: 10.3390/diagnostics10020100
pmc: PMC7167834
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Genomic population mapping of radioactively and heavy metals contaminated areas in order to increase national security-ARTEMIS
ID : PN-III-P1-1.2-PCCDI2017-0737

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

Int Surg. 2007 Jul-Aug;92(4):226-9
pubmed: 18050833
Clin Nucl Med. 2009 Mar;34(3):137-40
pubmed: 19352273
Indian J Nucl Med. 2012 Jan;27(1):38-41
pubmed: 23599598
Nucl Med Mol Imaging. 2011 Dec;45(4):324-5
pubmed: 24900025
Ann Oncol. 2019 Dec 1;30(12):1856-1883
pubmed: 31549998
J BUON. 2014 Apr-Jun;19(2):524-9
pubmed: 24965416
Singapore Med J. 2009 Feb;50(2):e61-4
pubmed: 19296013
Med Hypotheses. 1980 Feb;6(2):133-7
pubmed: 7393016
Oncol Lett. 2015 Feb;9(2):727-730
pubmed: 25621043
J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440
pubmed: 30545990
Clin Nucl Med. 2010 May;35(5):360-1
pubmed: 20395716
Virchows Arch. 2006 Jun;448(6):857-61
pubmed: 16568308
J Egypt Natl Canc Inst. 2015 Mar;27(1):47-50
pubmed: 25698468
Orphanet J Rare Dis. 2013 Aug 03;8:115
pubmed: 23915575
Chirurgia (Bucur). 2013 Jul-Aug;108(4):490-7
pubmed: 23958091
Thyroid. 2008 Jun;18(6):663-4
pubmed: 18578619
Eur Thyroid J. 2019 Oct;8(5):227-245
pubmed: 31768334
Medicine (Baltimore). 2016 Jan;95(4):e2532
pubmed: 26825891
Thyroid. 2011 Sep;21(9):1027-31
pubmed: 21834676
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967

Auteurs

Liviu Hitu (L)

Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Calin Cainap (C)

Department of Medical Oncology, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Dragos Apostu (D)

Department of Orthopedics and Traumatology, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Katalin Gabora (K)

Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Eduard-Alexandru Bonci (EA)

Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Marius Badan (M)

Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Alexandru Mester (A)

Department of Oral Health, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Andra Piciu (A)

Department of Medical Oncology, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Classifications MeSH